Robert Lustig: Life and Career

Table of Contents

1. Brooklyn, Stuyvesant and MIT
2. Medical School, Residency and the Endocrine Fellowship
3. Neuroendocrinology at The Rockefeller University
4. Wisconsin, Tennessee and St. Jude
5. UCSF from 2001 and the WATCH Program
6. Guideline Committees and Public Health Statements
7. Sugar: The Bitter Truth and the Public Turn
8. The Law Degree and Policy Work
9. His Books
10. Organisations, Teaching and Legacy
11. Timeline
12. Key Research Papers
13. Connections
14. Featured Videos

1. Brooklyn, Stuyvesant and MIT

Robert H. Lustig is a native of Brooklyn, New York. His own biography records that he attended Stuyvesant High School in Manhattan and then the Massachusetts Institute of Technology (MIT), where he graduated in 1976.

The science-heavy start matters for the rest of the story. Throughout his later work he describes obesity and chronic disease in the language of biochemistry and physiology — hormones, signals, energy partitioning inside cells — rather than in the language of willpower. In a 2006 review he put the idea in its best-known form, arguing that the usual reading of the First Law of Thermodynamics (eat more than you burn and you gain weight) has the order of events reversed: in his account the behaviours of eating more and moving less are “secondary to obligate weight gain”, driven by high insulin levels that push energy into fat cells and interfere with the brain’s fullness signal, leptin.

Back to Table of Contents

2. Medical School, Residency and the Endocrine Fellowship

Lustig earned his Doctor of Medicine (MD) degree at Cornell University Medical College in 1980. He then trained in pediatrics at St. Louis Children’s Hospital, completing his residency in 1983, and went on to a clinical fellowship in pediatric endocrinology at UCSF, which he completed in 1984. His active working life as a doctor therefore runs from 1983, when he became a pediatrician, to the present.

His first PubMed-indexed paper appeared in 1984. One of the earliest papers on which he is first author, published in the journal Pediatrics in 1985 with Kaplan and Grumbach at UCSF, tested how children whose growth-hormone production had been damaged by radiation treatment responded to growth hormone-releasing factor, the brain hormone that tells the pituitary gland to release growth hormone. The topic — the hormonal after-effects of cancer treatment in children — would return as the centre of his clinical research a decade later.

Back to Table of Contents

3. Neuroendocrinology at The Rockefeller University

After his fellowship, Lustig spent six years as a post-doctoral fellow and research associate in neuroendocrinology at The Rockefeller University in New York. Neuroendocrinology is the study of how the brain, and in particular the hypothalamus at the base of the brain, controls the hormone glands of the body. His own biography describes his training as being in “hypothalamic development, anatomy, and function”.

The papers from this period were laboratory work in rats, done with the neuroscientist Donald Pfaff and with Charles Mobbs and Bruce McEwen. A 1988 paper in the Journal of Endocrinology examined how the body’s own opioid signals modulate the surge of luteinising hormone that oestradiol triggers in female rats; a 1989 paper in Endocrinology compared the effects of oestradiol and a related oestrogen, 16α-hydroxyestrone, on oestrogen receptors in the rat pituitary gland and in a hypothalamic brain region. In the early 1990s he also built a cell model for studying how oestrogen acts on nerve cells, using cultured cells engineered to carry the oestrogen receptor (published in the Journal of Neuroscience in 1994). These were animal and cell studies, not studies in patients; they gave him the brain-hormone training he later applied to children with obesity.

Back to Table of Contents

4. Wisconsin, Tennessee and St. Jude

Lustig then held faculty posts at the University of Wisconsin–Madison and the University of Tennessee in Memphis. From the Wisconsin period comes his co-authorship of a short trial report in the Journal of the American Medical Association (JAMA) in 1994, on the drug pentoxifylline in children with newly diagnosed type 1 diabetes.

In Memphis he worked at St. Jude Children’s Research Hospital, the children’s cancer centre, until 2001. In his own words, he “was charged with the endocrine care of many children whose hypothalami had been damaged by brain tumors, or subsequent surgery, radiation, or chemotherapy. Many patients who survived became massively obese.”

Those children shaped everything that followed. As his biography tells it, the damage to the hypothalamus left them unable to sense the hormone leptin, which in turn “led to the starvation response”; the nerve that links the brain to the pancreas (the vagus nerve) became overactive and drove up insulin secretion. His team tried octreotide, a drug that damps down insulin release. In a 1999 pilot study of 8 children, published while he was in the Department of Pediatrics at the University of Tennessee, the children had gained an average of 6.0 kg in the six months before treatment and lost 4.8 kg during six months on octreotide. A double-blind, placebo-controlled trial in 18 young patients followed in 2003, along with a St. Jude analysis of which brain-tumour survivors went on to develop obesity. His biography adds that on octreotide the patients “started to exercise spontaneously”, and that he later showed “the same phenomenon in obese adults without CNS lesions”. He describes this work as the root of his “unifying hypothesis” about the wider obesity epidemic. The full clinical story is on the Hypothalamic Obesity page.

Back to Table of Contents

5. UCSF from 2001 and the WATCH Program

In 2001 Lustig returned to UCSF as a professor of pediatrics in the Division of Endocrinology. There he directed the Weight Assessment for Teen and Child Health (WATCH) program, a clinic for children and teenagers with obesity. UCSF Profiles now lists him as “Recall Professor, Pediatrics” — an emeritus professor recalled to service — and his own site signs him as professor emeritus and neuroendocrinologist. He is also a member of UCSF’s Philip R. Lee Institute for Health Policy Studies, the affiliation printed on several of his later papers.

His record at UCSF is mainly one of clinical and population research and of review writing. PubMed lists more than 160 papers under his name. His biography records that he has mentored 20 pediatric endocrine fellows. From UCSF came the review papers that set out his views on insulin, leptin and the brain’s reward system; the nine-day fructose-restriction study in children (see Fructose Restriction Studies); and collaborations on stress, eating and mindfulness. He also continued endocrine work on children treated for brain tumours, including long-term outcome studies with St. Jude colleagues.

Back to Table of Contents

6. Guideline Committees and Public Health Statements

Alongside his own research, Lustig has served on the committees that write professional advice on childhood obesity. His biography lists, without dates, these roles:

• former chairman of the Ad hoc Obesity Task Force of the Lawson Wilkins Pediatric Endocrine Society;
• member of the Pediatric Obesity Practice Guidelines Subcommittee and of the Obesity Task Force of the Endocrine Society;
• member of the Pediatric Obesity Devices Committee of the U.S. Food and Drug Administration;
• member of the Bay Area board of the American Heart Association;
• member of the steering committee of the “Healthy Foods, Healthy Kids” initiative of the Culinary Institute of America;
• endocrine support for treatment protocols of the Children’s Oncology Group.

Three published documents carry his name from this work. In 2005 he was among the authors of an international consensus statement on childhood obesity in the Journal of Clinical Endocrinology and Metabolism. In 2008 he co-authored the Endocrine Society’s clinical practice guideline on the prevention and treatment of pediatric obesity. In 2009 he was a co-author of the American Heart Association’s scientific statement “Dietary sugars intake and cardiovascular health”, the statement that set upper limits for added sugar; his site quotes those limits as about 6 teaspoons (25 grams) a day for women and 9 teaspoons (38 grams) a day for men.

Back to Table of Contents

7. Sugar: The Bitter Truth and the Public Turn

On 26 May 2009 Lustig gave a public lecture titled “Sugar: The Bitter Truth”, recorded at the UCSF Osher Center for Integrative Medicine in the university’s “Mini Medical School for the Public” series. His site summarises its argument in one sentence: “fructose (too much) and fiber (not enough) appear to be cornerstones of the obesity epidemic through their effects on insulin.” Shared on YouTube in 2009, the recording went on to reach millions of viewers and made him widely known outside medicine. A follow-up lecture in the same series, “Fat Chance: Fructose 2.0”, extended the argument; its host noted at the time how widely the first lecture had been downloaded.

Written versions followed. In 2010 he published “Fructose: metabolic, hedonic, and societal parallels with ethanol” in the Journal of the American Dietetic Association. On 1 February 2012, with Laura Schmidt and Claire Brindis, he published the commentary “The toxic truth about sugar” in Nature, whose standfirst reads: “Added sweeteners pose dangers to health that justify controlling them like alcohol”. The lecture, the fructose argument and the Nature commentary are covered on the Sugar: The Bitter Truth page.

His site describes the path in one line: the hypothalamic-obesity work at St. Jude led to a “unifying hypothesis” and then to “the specific role of fructose (half of sucrose and high-fructose corn syrup) as a specific mediator of both chronic disease, and continued caloric consumption.”

Back to Table of Contents

8. The Law Degree and Policy Work

In mid-career Lustig went back to school. He took a sabbatical and in 2013 earned a Master of Studies in Law (MSL) from the University of California, Hastings College of the Law in San Francisco. His biography gives the reason: he obtained it “to enable him to impact the food industry through policy change.” Since then he has signed his name Robert H. Lustig, MD, MSL; a 2013 interview in Pediatric Annals, “A conversation with Robert H. Lustig, MD, MSL”, records his career in his own words.

His policy work has taken several forms. With the cardiologist Aseem Malhotra and Grant Schofield he co-wrote a report in the Journal of Insulin Resistance titled “The science against sugar, alone, is insufficient…”, which sets out an eight-point plan including a tax on sugar, labelling of added sugar in teaspoons and limits on advertising. In a 2020 paper in Nutrients he argued that added sugar, and by extension ultra-processed food, meets “the four criteria set by the public health community as necessary and sufficient for regulation—abuse, toxicity, ubiquity, and externalities”. His site also lists him on the team of UCSF’s SugarScience initiative, which states that it reviewed “more than 8,000 scientific papers” on sugar and health.

Back to Table of Contents

9. His Books

Lustig has written or edited six books, listed here from his own site and library catalogues:

• Obesity Before Birth: Maternal and Prenatal Influences on the Offspring (editor). Endocrine Updates, volume 30. New York: Springer, 2011. A scientific volume on how conditions in the womb shape a child’s later risk of obesity.
• Fat Chance: Beating the Odds Against Sugar, Processed Food, Obesity, and Disease. New York: Hudson Street Press (Penguin), 2013. His first book for the general public; his site describes it as a New York Times bestseller translated into 11 languages. From its page: “The obesity pandemic is due to our altered biochemistry, which is a result of our altered environment.”
• Sugar Has 56 Names: A Shopper’s Guide. E-book. Hudson Street Press, 2013. A guide to the many names under which added sugar appears on food labels.
• The Fat Chance Cookbook, with Cindy Gershen (recipes) and Heather Millar. Hudson Street Press, 2014. The publisher’s text on his site describes its approach as reducing sugar, increasing fibre and reading labels for hidden sugars.
• The Hacking of the American Mind: The Science Behind the Corporate Takeover of Our Bodies and Brains. Avery (Penguin Random House), released 12 September 2017. His book on pleasure, happiness, dopamine and serotonin — see The Hacking of the American Mind.
• Metabolical: The Lure and the Lies of Processed Food, Nutrition, and Modern Medicine. HarperCollins, 4 May 2021. Its 1,054 references were published online instead of in print. See Metabolical and Processed Food.

He also wrote the introduction, titled “Prophecy and Propaganda” (pages vii–x), to the 2012 Penguin edition of the nutrition scientist John Yudkin’s book Pure, White and Deadly. There Lustig writes that the book “draws direct lines between sugar and dental caries, gout, autoimmune disease, heart disease, and cancer”, and that Yudkin “had correlation, but not causation. He didn’t have mechanism.” Supplying that mechanism is how Lustig frames much of his own work.

On cooking, which runs through the cookbook and his later writing, his site carries this sentence: “There is nothing that will improve your health, your well-being, your achievement, your sense of accomplishment, your sense of community, and the health and happiness of your family as much as cooking yourself and enjoying a meal with others.”

Back to Table of Contents

10. Organisations, Teaching and Legacy

Lustig’s name is attached to a research foundation of his own. His site describes the Robert H. Lustig Research Foundation (RHL Research Foundation) as a newly established independent foundation, with Wolfram Alderson as its founding chief executive, whose aims are applied research integrating “medical practice, translational science, public health education, law and science-based policy change”, educational programmes, and fellowships for early-career clinician-researchers.

In the conflict-of-interest statement of his 2020 Nutrients paper he lists his roles with non-profit groups: chief science officer of Eat REAL, a non-profit working on the quality of school food, and adviser to Action on Sugar in the United Kingdom and to the Center for Humane Technology in the United States.

His teaching reaches beyond the clinic. Besides the UCSF Mini Medical School lectures, he keeps his own YouTube channel of talks, and in 2022, with Fennoy, he published “The History of Obesity Research” in Hormone Research in Paediatrics, a review of how scientific thinking about obesity has changed over time. He is still publishing: a 2025 paper in Frontiers in Psychiatry, “The battle over ‘food addiction’”, sets out his current view of the mechanisms behind compulsive eating.

On the personal side, his biography says only that he lives in San Francisco with his wife, Julie, and their two daughters.

Back to Table of Contents

11. Timeline

• 1976 — graduates from the Massachusetts Institute of Technology.
• 1980 — Doctor of Medicine, Cornell University Medical College.
• 1983 — completes pediatric residency at St. Louis Children’s Hospital.
• 1984 — completes clinical fellowship in pediatric endocrinology at UCSF; first PubMed-indexed paper.
• Late 1980s — six years of neuroendocrinology research at The Rockefeller University (rat studies with Pfaff, Mobbs and McEwen, 1988–1989).
• 1990s — faculty posts at the University of Wisconsin–Madison and the University of Tennessee, Memphis; endocrine care of brain-tumour survivors at St. Jude Children’s Research Hospital.
• 1999 — first octreotide study in 8 children with hypothalamic obesity.
• 2001 — joins UCSF as professor of pediatrics; later directs the WATCH program.
• 2003 — double-blind, placebo-controlled octreotide trial in 18 young patients; St. Jude risk-factor study.
• 2006 — review reinterpreting the First Law of Thermodynamics for childhood obesity.
• 2008 — co-author of the Endocrine Society pediatric obesity guideline.
• 2009 — co-author of the American Heart Association statement on dietary sugars; lecture “Sugar: The Bitter Truth” (26 May).
• 2010 — paper on parallels between fructose and ethanol.
• 2011 — Obesity Before Birth (editor).
• 2012 — Nature commentary “The toxic truth about sugar” (1 February); introduction to Yudkin’s Pure, White and Deadly.
• 2013 — Master of Studies in Law; Fat Chance; Sugar Has 56 Names.
• 2014 — The Fat Chance Cookbook.
• 2015–2016 — nine-day fructose-restriction study in 43 children published.
• 2017 — The Hacking of the American Mind (12 September).
• 2020 — paper arguing ultra-processed food meets the four criteria for regulation.
• 2021 — Metabolical (4 May).
• 2022 — “The History of Obesity Research” (with Fennoy).
• 2025 — “The battle over ‘food addiction’”.

Back to Table of Contents

Key Research Papers

1. Lustig RH, Schriock EA, Kaplan SL, Grumbach MM. Effect of growth hormone-releasing factor on growth hormone release in children with radiation-induced growth hormone deficiency. Pediatrics. 1985;76(2):274-9. — PubMed PMID: 3927254
2. Lustig RH, Pfaff DW, Fishman J. Opioidergic modulation of the oestradiol-induced LH surge in the rat: roles of ovarian steroids. J Endocrinol. 1988;116(1):55-69. — PubMed PMID: 3339293
3. Lustig RH, Mobbs CV, Bradlow HL, McEwen BS, Pfaff DW. Differential effects of estradiol and 16 alpha-hydroxyestrone on pituitary and preoptic estrogen receptor regulation. Endocrinology. 1989;125(5):2701-9. — PubMed PMID: 2792004
4. Lustig RH, Hua P, Yu W, Ahmad FJ, Baas PW. An in vitro model for the effects of estrogen on neurons employing estrogen receptor-transfected PC12 cells. J Neurosci. 1994;14(6):3945-57. — PubMed PMID: 8207498
5. MacDonald MJ, Shahidi NT, Allen DB, Lustig RH, Mitchell TL, Cornwell ST. Pentoxifylline in the treatment of children with new-onset type I diabetes mellitus. JAMA. 1994;271(1):27-8. — PubMed PMID: 8258882
6. Lustig RH, Rose SR, Burghen GA, Velasquez-Mieyer P, Broome DC, Smith K, et al. Hypothalamic obesity caused by cranial insult in children: altered glucose and insulin dynamics and reversal by a somatostatin agonist. J Pediatr. 1999;135(2 Pt 1):162-8. — PubMed PMID: 10431109
7. Lustig RH, Hinds PS, Ringwald-Smith K, Christensen RK, Kaste SC, Schreiber RE, et al. Octreotide therapy of pediatric hypothalamic obesity: a double-blind, placebo-controlled trial. J Clin Endocrinol Metab. 2003;88(6):2586-92. — PubMed PMID: 12788859
8. Speiser PW, Rudolf MC, Anhalt H, Camacho-Hubner C, Chiarelli F, Eliakim A, et al. Childhood obesity. J Clin Endocrinol Metab. 2005;90(3):1871-87. — PubMed PMID: 15598688
9. Lustig RH. Childhood obesity: behavioral aberration or biochemical drive? Reinterpreting the First Law of Thermodynamics. Nat Clin Pract Endocrinol Metab. 2006;2(8):447-58. — PubMed PMID: 16932334
10. August GP, Caprio S, Fennoy I, Freemark M, Kaufman FR, Lustig RH, et al. Prevention and treatment of pediatric obesity: an endocrine society clinical practice guideline based on expert opinion. J Clin Endocrinol Metab. 2008;93(12):4576-99. — PubMed PMID: 18782869
11. Johnson RK, Appel LJ, Brands M, Howard BV, Lefevre M, Lustig RH, et al. Dietary sugars intake and cardiovascular health: a scientific statement from the American Heart Association. Circulation. 2009;120(11):1011-20. — PubMed PMID: 19704096
12. Lustig RH. Fructose: metabolic, hedonic, and societal parallels with ethanol. J Am Diet Assoc. 2010;110(9):1307-21. — PubMed PMID: 20800122
13. Lustig RH, Schmidt LA, Brindis CD. Public health: The toxic truth about sugar. Nature. 2012;482(7383):27-9. — PubMed PMID: 22297952
14. Lustig RH. A conversation with Robert H. Lustig, MD, MSL. Interview by Stanford T Shulman. Pediatr Ann. 2013;42(7):296. — PubMed PMID: 23805972
15. Lustig RH. Ultraprocessed Food: Addictive, Toxic, and Ready for Regulation. Nutrients. 2020;12(11):3401. — PubMed PMID: 33167515
16. Lustig RH, Fennoy I. The History of Obesity Research. Horm Res Paediatr. 2022;95(6):638-648. — PubMed PMID: 36446324
17. Lustig RH. The battle over “food addiction”. Front Psychiatry. 2025;16:1621742. — PubMed PMID: 40950761

PubMed Topic Searches

1. https://pubmed.ncbi.nlm.nih.gov/?term=Lustig+RH%5Bau%5D
2. https://pubmed.ncbi.nlm.nih.gov/?term=Lustig+RH%5Bau%5D+hypothalamic+obesity
3. https://pubmed.ncbi.nlm.nih.gov/?term=Lustig+RH%5Bau%5D+fructose
4. https://pubmed.ncbi.nlm.nih.gov/?term=Lustig+RH%5Bau%5D+pediatric+obesity+guideline

Further Reading

• Robert H. Lustig. “About” (his own biography). https://robertlustig.com/about/
• Robert H. Lustig. “Books”. https://robertlustig.com/books/
• Robert H. Lustig. “Sugar: The Bitter Truth” (lecture page). https://robertlustig.com/sugar-the-bitter-truth/
• Robert H. Lustig. “Fat Chance: Fructose 2.0” (lecture transcript). https://robertlustig.com/fructose2/
• Robert H. Lustig. “Policy Initiatives”. https://robertlustig.com/policy/
• Robert H. Lustig. “Real Food”. https://robertlustig.com/real-food/
• RHL Research Foundation. https://robertlustig.com/rhl-research-foundation/
• UCSF Profiles. “Robert Lustig”. https://profiles.ucsf.edu/robert.lustig
• Lustig RH, Schmidt LA, Brindis CD. “The toxic truth about sugar”. Nature 482:27–29 (2012), article page. https://www.nature.com/articles/482027a

Back to Table of Contents

Connections

• Dr. Robert Lustig: Sugar, Fructose and Metabolic Health
• Sugar: The Bitter Truth and the Fructose Argument
• Fructose Restriction Studies in Children
• Hypothalamic Obesity and Insulin: Lustig’s Clinical Research
• Metabolical and Lustig’s Case Against Processed Food
• The Hacking of the American Mind
• Contemporary Practitioners
• Obesity
• History of Obesity
• Added Sugar and Weight
• Metabolic Syndrome
• Hypopituitarism

Featured Videos